We’re committed to reducing our impact throughout a product’s lifecycle—from design, through material sourcing and manufacturing, to packaging and delivery, and product use and end-of-life.
- The plastic trays used in our plaque psoriasis line of medicines were replaced with a Pulp Injection Molding (PIM) tray across all markets. The use of injection-molded pulp is a significant breakthrough in pharmaceutical packaging, particularly since PIM trays can be disposed of through regular cardboard recycling waste streams, available in most countries.
- Our Safe Returns® program for home-administered immunology products was recently redesigned to improve convenience and sustainability for patients, including the removal of the hazardous material classification which eliminates the need for patients to prepare special paperwork for handling by mainstream postal services. Additionally, the new system uses paper envelopes to return the devices after use instead of plastic containers. The program is available in the US and in select countries in Europe.